Bonesupport Holding (BONEX.ST) Stock Analysis & AI Equity Report
Bonesupport Holding (BONEX.ST) overview
Bonesupport Holding (BONEX.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Bonesupport Holding reported revenue of SEK 899m and operating profit of SEK 166m; the year-end share price was 391.60 SEK and market capitalisation was SEK 25,701m. Bonesupport Holding is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Bonesupport Holding's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-05. Data will be refreshed during report generation.
About Bonesupport Holding
BONESUPPORT Holding AB is a Scandinavian orthobiologics company that develops and commercializes CERAMENT, a range of injectable bioceramic bone graft substitutes used to treat fractures and bone voids caused by trauma, infection, disease or surgery. Its products are designed to remodel to host bone and can also elute drugs.
Generate the Bonesupport Holding report
Bonesupport Holding is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Bonesupport Holding and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.